Revolution Medicines, Inc.

NasdaqGS:RVMD 株式レポート

時価総額：US$6.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Revolution Medicines マネジメント

マネジメント 基準チェック /34

Revolution Medicines'の CEO はMark Goldsmithで、 Nov2014年に任命され、 の在任期間は 9.58年です。 の年間総報酬は$ 10.41Mで、 6.1%給与と93.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.37%を直接所有しており、その価値は$ 24.07M 。経営陣と取締役会の平均在任期間はそれぞれ6年と7.5年です。

主要情報

Mark Goldsmith

最高経営責任者

US$10.4m

報酬総額

CEO給与比率6.1%
CEO在任期間9.6yrs
CEOの所有権0.4%
経営陣の平均在職期間6yrs
取締役会の平均在任期間7.5yrs

経営陣の近況

Recent updates

Revolution Medicines: On Hold Pending A Lower Entry Point

Jun 04

Revolution Medicines: An Expensive Shot At A Massive Market Opportunity

Apr 12

Revolution Medicines Is Hard To Understand

Feb 01

Here's Why We're Not Too Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Situation

Some Analysts Just Cut Their Revolution Medicines, Inc. (NASDAQ:RVMD) Estimates

May 13
Some Analysts Just Cut Their Revolution Medicines, Inc. (NASDAQ:RVMD) Estimates

We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth

Apr 02
We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth

We're Hopeful That Revolution Medicines (NASDAQ:RVMD) Will Use Its Cash Wisely

Dec 20
We're Hopeful That Revolution Medicines (NASDAQ:RVMD) Will Use Its Cash Wisely

We're Not Very Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Rate

Sep 15
We're Not Very Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Rate

Revolution Medicines promotes Jack Anders to CFO

Sep 02

New Forecasts: Here's What Analysts Think The Future Holds For Revolution Medicines, Inc. (NASDAQ:RVMD)

Aug 10
New Forecasts: Here's What Analysts Think The Future Holds For Revolution Medicines, Inc. (NASDAQ:RVMD)

Revolution Medicines to raise up to $200M in stock offering

Jul 19

Revolution Medicines, Inc. (NASDAQ:RVMD) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 11
Revolution Medicines, Inc. (NASDAQ:RVMD) Analysts Just Slashed This Year's Revenue Estimates By 11%

We're Hopeful That Revolution Medicines (NASDAQ:RVMD) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Revolution Medicines (NASDAQ:RVMD) Will Use Its Cash Wisely

Revolution Medicines (NASDAQ:RVMD) Is In A Good Position To Deliver On Growth Plans

Dec 16
Revolution Medicines (NASDAQ:RVMD) Is In A Good Position To Deliver On Growth Plans

What Does The Future Hold For Revolution Medicines, Inc. (NASDAQ:RVMD)? These Analysts Have Been Cutting Their Estimates

Aug 17
What Does The Future Hold For Revolution Medicines, Inc. (NASDAQ:RVMD)? These Analysts Have Been Cutting Their Estimates

CEO報酬分析

Revolution Medicines の収益と比較して、Mark Goldsmith の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$484m

Dec 31 2023US$10mUS$631k

-US$436m

Sep 30 2023n/an/a

-US$331m

Jun 30 2023n/an/a

-US$296m

Mar 31 2023n/an/a

-US$259m

Dec 31 2022US$7mUS$607k

-US$249m

Sep 30 2022n/an/a

-US$245m

Jun 30 2022n/an/a

-US$224m

Mar 31 2022n/an/a

-US$208m

Dec 31 2021US$8mUS$581k

-US$187m

Sep 30 2021n/an/a

-US$169m

Jun 30 2021n/an/a

-US$143m

Mar 31 2021n/an/a

-US$126m

Dec 31 2020US$2mUS$554k

-US$110m

Sep 30 2020n/an/a

-US$95m

Jun 30 2020n/an/a

-US$85m

Mar 31 2020n/an/a

-US$71m

Dec 31 2019US$5mUS$504k

-US$62m

Sep 30 2019n/an/a

-US$57m

Dec 31 2018US$1mUS$490k

-US$49m

報酬と市場: Markの 総報酬 ($USD 10.41M ) は、 US市場 ($USD 8.45M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Markの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Mark Goldsmith (62 yo)

9.6yrs

在職期間

US$10,411,247

報酬

Dr. Mark A. Goldsmith, M.D., Ph.D. is the Chief Executive Officer, President and Director of Revolution Medicines, Inc. since November 2014 and serves as its Chairman. Dr. Goldsmith served as a Venture Par...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mark Goldsmith
CEO, President & Chairman9.6yrsUS$10.41m0.37%
$ 24.5m
Jack Anders
Chief Financial Officer5.8yrsUS$3.05m0.025%
$ 1.7m
Margaret Horn
Chief Operating Officer5.7yrsUS$4.39m0.028%
$ 1.8m
Stephen Kelsey
President of Research & Development7.3yrsUS$4.39m0.10%
$ 6.6m
Xiaolin Wang
Executive Vice President of Development6.3yrsUS$3.23m0.016%
$ 1.0m
Martin Burke
Co-Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Michael Fischbach
Academic Co-Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Kevan Shokat
Academic Co-Founder & Member of Scientific Advisory Board7.5yrsデータなしデータなし
Walter Reiher
Chief Information Officerno dataデータなしデータなし
Jan Smith
Chief Scientific Officerless than a yearデータなしデータなし
Erin Graves
Senior Director of Corporate Communications & Investor Relationsno dataデータなしデータなし
Jeff Cislini
Senior VP1.8yrsデータなし0.0024%
$ 155.4k

6.0yrs

平均在職期間

53yo

平均年齢

経験豊富な経営陣: RVMDの経営陣は経験豊富で経験豊富です（平均在職期間は6年）。

取締役

名称ポジション在職期間報酬所有権
Mark Goldsmith
CEO, President & Chairman9.6yrsUS$10.41m0.37%
$ 24.5m
Martin Burke
Co-Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Michael Fischbach
Academic Co-Founder & Member of Scientific Advisory Board8yrsデータなしデータなし
Kevan Shokat
Academic Co-Founder & Member of Scientific Advisory Board7.5yrsデータなしデータなし
Julian Adams
Senior Advisor & Member of Scientific Advisory Board7.5yrsデータなしデータなし
Alexis Borisy
Lead Independent Director9.6yrsUS$510.63k1.41%
$ 92.4m
Eric Gordon
Senior Advisor & Member of Scientific Advisory Board8yrsデータなしデータなし
John Kuriyan
Senior Advisor & Member of Scientific Advisory Board7.5yrsデータなしデータなし
Lorence Kim
Independent Director1.9yrsUS$489.99k0.033%
$ 2.2m
Thilo Schroeder
Independent Director6.3yrsデータなしデータなし
Elizabeth Anderson
Independent Director9.3yrsUS$483.78k0.023%
$ 1.5m
Trever Bivona
Senior Advisor & Member of Scientific Advisory Board7.5yrsデータなしデータなし

7.5yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: RVMDの 取締役会 は 経験豊富 であると考えられます ( 7.5年の平均在任期間)。